New NCI Director Plans Greater Support For Translational Research, Collaboration.
HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.
French Legion d’Honneur Bestowed On Hortobagyi.
Mammography Summit Planned For June In Milan.
Urgent Need For New Drugs To Treat Pre-Cancers: AACR.
Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.
FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.
American Home Products Changes Name To Wyeth.
Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- John Burklow replaced by Seana Cranston as NIH chief of staff









